Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2005
10/12/2005CN1681815A Compositions useful as inhibitors of GSK-3
10/12/2005CN1681808A N-substituted-1H-indol-5-propionic acid compounds as PPAR agonists useful for the treatment of diabetes
10/12/2005CN1681806A Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681784A Azabicyclo derivatives as muscarinic receptor antagonists
10/12/2005CN1681781A 新的二氢吲哚化合物和其医药用途 New indoline compound and pharmaceutical use
10/12/2005CN1681770A Amino-propanol derivatives
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681532A Therapeutics for diabetes mellitus
10/12/2005CN1681524A Body fat percentage-lowering agent or body fat percentage increase inhibitor
10/12/2005CN1681523A Composition and method for lowering cholesterol
10/12/2005CN1681514A A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus
10/12/2005CN1681508A Novel inhibitors of kinases
10/12/2005CN1681499A Medicinal composition for mitigating blood lipid or lowering blood homocysteine
10/12/2005CN1681498A Diaryl ethers as opioid receptor antagonist
10/12/2005CN1680603A ANGPTL4/FIAF as marker for PPAR delta modulation
10/12/2005CN1680578A Preparation of oyster bioactive peptide
10/12/2005CN1680551A Gene of regulating epithelial cell channel of small intestine and its preparation and use
10/12/2005CN1680546A Acid and choline-resistant separated strain of lactobacillus with ability of reducing and assimilating cholesterol
10/12/2005CN1680545A Acid and choline-resistant separated strain of lactobacoillus with ability of reducing and assimilating cholesterol
10/12/2005CN1680544A Acid and choline-resistant separated strain of lactobacillus with ability of reducing and assimilating cholesterol
10/12/2005CN1680543A Acid and choline-resistant separated strain of lactobacillus with ability of reducing and assimilating cholesterol
10/12/2005CN1680542A Acid and choline-resistant separated strain of lactobacillus with ability of reducing and assimilating cholesterol
10/12/2005CN1680440A Batyl active peptide, preparation and therepic use thereof
10/12/2005CN1680379A 2-pyridinyl-6, 7, 8, 9-tetrahydropyrimido{1, 2-a}pyrimidin-4-one and 7-pyridinyl-1, 3-dihydoimidazo{1, 2-a}pyrimidin-5(1h)one derivatives
10/12/2005CN1680378A Pyrazolo(4, 3-d)pyrimidine derivatives
10/12/2005CN1680371A Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds
10/12/2005CN1680364A Method for producing lipoic acid and dihydrolipoic acid
10/12/2005CN1680341A Valsartan salts
10/12/2005CN1680339A Benzimidazole derivative
10/12/2005CN1680308A New 3-aryl-2-hydroxypropionic acid derivative I
10/12/2005CN1680284A New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
10/12/2005CN1680238A Preparation and use of compounds i.e., 1, 3-dihydroxy-5-alkyl benzene as inhbitor of protein-tyrosine-phosphatase 1B
10/12/2005CN1680235A Preparation and use of compounds i.e., falcarindiol as inhibitor of protein-tyrosine-phosphatase 1B
10/12/2005CN1679924A Compound insulin energy mistura preparation and use thereof
10/12/2005CN1679918A Medical use of interleukin-22
10/12/2005CN1679914A Medicinal composition of induced glutathione and ebeselen
10/12/2005CN1679912A Extraction of liuwei Dihuang polysaccharide, products and use thereof
10/12/2005CN1679897A Bioamino acid capsules and preparation thereof
10/12/2005CN1679885A Medicinal composition for diabete and its making method
10/12/2005CN1679879A Kouweishu tablets
10/12/2005CN1679869A Preparation for diabetes and its making method
10/12/2005CN1679866A Rhizome Anemarrhenae use of medicine preparation for treating or preventing diabetes mellitus
10/12/2005CN1679860A Medicine for treating diabetes mellitus
10/12/2005CN1679851A Bee product tablets for diabetes and their making method
10/12/2005CN1679844A Chinese medicine capsules for treating coronary heart disease and hyperlipidemia and production thereof
10/12/2005CN1679827A Method for making substrate for paste from Chinese prickly ash and oral medicinal materials
10/12/2005CN1679822A Oral medicine for treating hyperlipemia
10/12/2005CN1679820A Oral medicine for treating diabetes
10/12/2005CN1679656A Prescription of ecologic synchronous treatment
10/12/2005CN1679655A Effective component of encrinite and hypoglycemic activity
10/12/2005CN1679628A Yak myeloid calcium tablets
10/12/2005CN1679617A Microbiotic polysaccharide use of antineoplastic, hypoglycemic and hypolipidemic medicine
10/12/2005CN1679615A Compound infantile energy mistura soluble vitamin preparation and use thereof
10/12/2005CN1679613A Compound aspartic acid potassium magnesium energy mistura vitamin preparation and use thereof
10/12/2005CN1679610A Compound aspartic acid ornithine energy mistura and use thereof
10/12/2005CN1679609A Compound energy mistura fat-soluble vitamins adult preparation and use thereof
10/12/2005CN1679601A Use of lotus flavone in triglyceride for reducing hyperlipemia
10/12/2005CN1679593A Composite preparation containing alpha-linolenic acid free acid, soybean phospholipid and vitamin E
10/12/2005CN1679582A Composite vitamin B powdery injection for venous infusion and preparation thereof
10/12/2005CN1679581A Composition of an external dermatological agent and fibers with effect of promoting lipid decomposition
10/12/2005CN1679577A Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
10/12/2005CN1679564A Method of treating of demyelinating diseases or conditions
10/12/2005CN1679556A Valdecoxib compositions
10/12/2005CN1679550A Sustained preparation of miglitol and its preparing agent
10/12/2005CN1679548A Composition containing lovastatin and use thereof
10/12/2005CN1679547A Blood-fat regulating medicinal composition and use thereof
10/12/2005CN1679541A Tea pigment drops and preparation thereof
10/12/2005CN1679540A Medicine against fungus
10/12/2005CN1679533A Levo carnitine dropping pill and preparation thereof
10/12/2005CN1679532A Therapeutic and dietary compositions
10/12/2005CN1679529A Chinese medicinal hypoglycemic agent and preparation thereof
10/12/2005CN1222524C Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2, 4-dione maleate and process for their preparation
10/12/2005CN1222522C Diphenyl azetidinone derivatives, method for prodn. thereof medicaments contg. these compounds, and their use
10/12/2005CN1222520C Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
10/12/2005CN1222507C Process for production of calcium pantothenate
10/12/2005CN1222374C Extrusion die
10/12/2005CN1222306C Blood sugar and urine glucose lowering capsule
10/12/2005CN1222290C Novel composition and use thereof
10/12/2005CN1222288C Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
10/12/2005CN1222284C High lipid diet
10/12/2005CN1222217C Process for preparing multi-vitamine bone peptide extract
10/11/2005US6953865 reacting (R)- or (S)- nitryloxycarnitine with sodium azide; hydrogenation to the intermediate azidocarnitine of same configuration; no isolation
10/11/2005US6953838 Urocortin-III and uses thereof
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/11/2005US6953806 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/11/2005US6953803 Pyrimidine compounds
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953798 compounds are able to inhibit binding of alpha 4 integrins to their ligands and are of use in prophylaxis and treatment of immune or inflammatory disorders
10/11/2005US6953797 Nitric oxide synthase inhibitor; antiinflammatory agents
10/11/2005US6953796 Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase
10/11/2005US6953791 Dipeptide derivatives
10/11/2005US6953787 5HT2C receptor modulators
10/11/2005US6953681 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/11/2005US6953595 Inhibitors of apoptosis of nerve cells
10/11/2005US6953591 Administering to a mammal non-toxic effective T-cell function-mediated disorder-treating amount of phosphatidyl serine (PS) carrying bodies wherein progression of T-cell function-mediated disorder is inhibited
10/11/2005US6953583 Use of conjugated linoleic acid (CLA) for the topical treatment of cellulite
10/11/2005US6953578 Administering a prostaglandin-2 synthase inhibitor selected from indomethacin, animoguanadine or N-(2-(cyclohexyloxy)-4-nitrophenyl)methanesulfonamide for preventing or reducing severity of autoimmune disease
10/11/2005CA2358773C Improved controlled release compositions and method
1 ... 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 ... 1298